Skip to main content
. 2022 Jun 1;24(8):1256–1266. doi: 10.1093/europace/euac050

Table 5.

Adverse events

N (%)
Major complications 29 (1.6%)
 Oesophageal fistula 0
 Oesophageal dysmotility 0
 Pulmonary vein stenosis 0
 Pericardial tamponade 17 (0.97)
  Percutaneous treatment 13 (0.74)
  Surgical treatment 4 (0.23)
 Stroke 7 (0.39)a
 Phrenic nerve injury (persistent) 0
 Vascular complications requiring surgery 4 (0.23)
 Coronary artery spasm 1 (0.06)
 Death 1 (0.06)a
Minor complications 68 (3.86%)
 TIA 2 (0.11)
 Phrenic nerve injury (transient)
  Transient effect 8 (0.46)
  Sustained effectb 0
 Vascular
  Hematoma 43 (2.44)
  Pseudoaneurysm 4 (0.22)
  AV fistula 3 (0.17)
  Other 6 (0.34)
 Other complications 2 (0.11)
a

One patient who sustained a stroke subsequently died.

b

Defined as persisting beyond hospital discharge.